Ultra-Long-Acting β2-Adrenoceptor Agonists: An Emerging Therapeutic Option for Asthma and COPD?

ISSN： 0012-6667

Source： Drugs, Vol.67, Iss.4, 2007-01, pp. : 503-515

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Acting β2-Agonists in Asthma: Not so SMART?

By Currie Graeme P.

Drug Safety, Vol. 29, Iss. 8, 2006-01 ,pp. : 647-656

Adis International

Access to resources Recommend Favorite

Long-Acting β-Agonists in Asthma Management: What is the Current Status?

By Mysore Satya

Drugs, Vol. 71, Iss. 16, 2011-11 ,pp. : 2091-2097

Adis International

Access to resources Recommend Favorite

Long-acting 2 agonists as potential option in the treatment of acute exacerbations of COPD

By Cazzola M. Matera M.G.

Pulmonary Pharmacology & Therapeutics, Vol. 16, Iss. 4, 2003-07 ,pp. : 197-201

Elsevier

Access to resources Recommend Favorite

Ultra long-acting β₂-agonists in development for asthma and chronic obstructive pulmonary disease

By Cazzola Mario Matera Maria Gabriella Lötvall Jan

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 7, 2005-07 ,pp. : 775-783

Informa Healthcare

Access to resources Recommend Favorite

Nocturnal Asthma Uncontrolled by Inhaled Corticosteroids: Theophylline or Long-Acting Agonists?

By Holimon T.D.

Drugs, Vol. 61, Iss. 3, 2001-01 ,pp. : 391-418

Adis International

Access to resources Recommend Favorite